Medications

Weekly dupilumab beneficial in eosinophilic esophagitis

Subcutaneous dupilumab administered weekly is associated with improved histologic outcomes and alleviation of symptoms among patients with eosinophilic esophagitis, according to a study published in the Dec. 22 issue of the ...

Pediatrics

A new way to improve outcomes in kids with eosinophilic esophagitis

A new study from Ann & Robert H. Lurie Children's Hospital of Chicago determined the threshold for a new measure of early scarring in the esophagus of children with eosinophilic esophagitis (EoE), which allows immediate intervention ...

Immunology

Monoclonal antibody reduces asthma attacks in urban youth

A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone ...

Immunology

'Bad guy' blood cells vital to gut health found

A Monash University collaboration has found that eosinophils, a type of white blood cell commonly associated with asthma and allergy, play an important role in maintaining a healthy gut.

Genetics

Discovery of gene defect for allergy and autoimmune diseases

An international team led by a physician from the Karl Landsteiner University for Health Sciences, Krems, describes for the first time a mutation of the IL-33 gene in the human genome that results in multiple allergic disease ...

page 2 from 9